Literature DB >> 18366176

Identification of promiscuous small molecule activators in high-throughput enzyme activation screens.

David R Goode1, Ryan K Totten, James T Heeres, Paul J Hergenrother.   

Abstract

It is recognized that high-throughput enzyme inhibition screens often return nonspecific inhibitors as "hits". Recently, high-throughput screens for enzyme activators have led to the identification of several compounds with novel and potent biological activity. Here, we show that enzyme activation screens can also uncover compounds that activate multiple enzymes in a nonspecific fashion. Described herein are the general structural features of such compounds and methods to differentiate between specific and general enzyme activation.

Mesh:

Substances:

Year:  2008        PMID: 18366176     DOI: 10.1021/jm701583b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Solubility at the molecular level: development of a critical aggregation concentration (CAC) assay for estimating compound monomer solubility.

Authors:  Jie Wang; Edmund Matayoshi
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

2.  Integrating computational and mixture-based screening of combinatorial libraries.

Authors:  Austin B Yongye; Clemencia Pinilla; Jose L Medina-Franco; Marc A Giulianotti; Colette T Dooley; Jon R Appel; Adel Nefzi; Thomas Scior; Richard A Houghten; Karina Martínez-Mayorga
Journal:  J Mol Model       Date:  2010-09-21       Impact factor: 1.810

3.  Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation.

Authors:  Julie A Zorn; Holger Wille; Dennis W Wolan; James A Wells
Journal:  J Am Chem Soc       Date:  2011-11-17       Impact factor: 15.419

4.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

Review 5.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

6.  Cell-permeable, small-molecule activators of the insulin-degrading enzyme.

Authors:  Sayali S Kukday; Surya P Manandhar; Marissa C Ludley; Mary E Burriss; Benjamin J Alper; Walter K Schmidt
Journal:  J Biomol Screen       Date:  2012-06-26

7.  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.

Authors:  Howard S Roth; Rachel C Botham; Steven C Schmid; Timothy M Fan; Levent Dirikolu; Paul J Hergenrother
Journal:  J Med Chem       Date:  2015-04-20       Impact factor: 7.446

8.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.

Authors:  Ajit Jadhav; Rafaela S Ferreira; Carleen Klumpp; Bryan T Mott; Christopher P Austin; James Inglese; Craig J Thomas; David J Maloney; Brian K Shoichet; Anton Simeonov
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

9.  Effects of detergents on the West Nile virus protease activity.

Authors:  Manolya D Ezgimen; Niklaus H Mueller; Tadahisa Teramoto; R Padmanabhan
Journal:  Bioorg Med Chem       Date:  2009-04-01       Impact factor: 3.641

10.  Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries.

Authors:  Henrike Veith; Noel Southall; Ruili Huang; Tim James; Darren Fayne; Natalia Artemenko; Min Shen; James Inglese; Christopher P Austin; David G Lloyd; Douglas S Auld
Journal:  Nat Biotechnol       Date:  2009-10-25       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.